학술논문
Low-dose versus standard-dose olanzapine with triple antiemetic therapy for prevention of highly emetogenic chemotherapy-induced nausea and vomiting in patients with solid tumours: a single-centre, open-label, non-inferiority, randomised, controlled, phase 3 trial
Document Type
Article
Author
Bajpai, Jyoti ; Kapu, Venkatesh; Rath, Sushmita; Kumar, Sravan; Sekar, Anbarasan; Patil, Priyanka; Siddiqui, Altaf; Anne, Srikanth; Pawar, Akash; Srinivas, Sujay; Bhargava, Prabhat; Gulia, Seema; Noronha, Vanita; Joshi, Amit; Prabhash, Kumar; Banavali, Shripad; Sarin, Rajiv; Badwe, Rajendra; Gupta, Sudeep
Source
In The Lancet Oncology February 2024 25(2):246-254
Subject
Language
ISSN
1470-2045